By utilizing the open-access tool from the Human Protein Atlas and investigating whether expression of IL-17RA has any prognostic value, it is evident that IL-17RA expression is a favorable prognostic marker for stomach cancer survival (p < 0.001, Fig. 1). This evidence concerns the gene IL17RA and gastric cancer.